Wednesday, September 3, 2014

AcuBack System

Just wanted to let you know that we now have the AcuBack System back in stock.  Please see link.  Also, we are offering an end of summer discount of 10%.  Use code TAKE10 at checkout.

http://shop.acuknee.com/AcuBack-Chronic-Back-Pain-Treatment-System-101.htm

Monday, June 2, 2014

Good afternoon,

Sorry I haven't been very active lately, but AcuKnee has been very busy.  Thanks to everyone who has supported us for the past year.  As a thanks we are offering a 10 promotion TAKE10 for the month of June.

Martin Brown, MD.
http://www.acuknee.com
www.acuknee.com
http://www.acuknee.com

Friday, April 11, 2014



"Because No One Should Live in Pain"

The AcuKnee System is different from TENS for many reasons.  The first being our AcuKnee Electrotherapy technology is completely reconfigured with a proprietary sequence and frequency.  In addition, our device comes with the only OTC HAN frequency mode.  There is a high cost associated with meeting FDA OTC requirements and manufacturing to non-standard specifications.  Our device is the only one of its kind approved by the FDA for sale OTC without a prescription.   TENS devices typically only provide brief pain relief.  Our proprietary AcuKnee program provides pain relief that last 24 to 72 hours.  Our System has been shown to suppress IL-1 and provide durable pain relief.  We guarantee a minimum 50% reduction in the KOOS score and a high percentage of our patients are completely pain free.  In addition, our system is a full functioning NMES device for enhancement of muscle strength and decreased post-exercise soreness.  No other device approaches our durable KOOS score improvement.

The FDA requires a prescription to purchase an actual TENS device.  If you see an actual TENS device for sale OTC it is illegal in the US.  Most devices you see are muscle stimulation devices only, not TENS.  


We’ve spent the past several years studying the acupuncture points and the most effective electrode placement for treating knee and back conditions.  Our treatment protocol was completely developed by a certified anesthesiologist who understands the nerves and pain points in the body for the most effective treatment.

Our system comes with a patent pending innovative wrap that makes treating at precise points much easier.  It is precision neuro-modulation.  Our wrap comes with predefined electrode placement locations and doesn’t require any work to treat the precise locations.  Our unit, using a highly conductive gel, gives uniform delivery across the entire electrode.  Our electrodes require infrequent replacing which reduces overall costs.

Compared to similar treatment devices, see Bionicare, Orthocore, AMP Ortho and the IVIVI device, our device is a fraction of the cost and these devices require a prescription.    The AcuKnee is revolutionary Neuro-Modulation.

We offer patients an alternative treatment option that doesn’t require surgery and frequent visits to the doctor, both of which have exorbitant cost.  We offer a 30 day money back guarantee, which is unheard of in the medical industry and our treatment works.  You may be interested to know that our product return rate is less than 2%.  We are rapidly developing ad-on devices that are plug_and_play with our electrotherapy units.  Our guiding corporate principal is the simple fact that we believe “No One Should Live in Pain”.

Martin Brown, M.D.

Thursday, March 27, 2014

http://wkzo.com/news/articles/2014/mar/27/knee-arthritis-more-likely-after-acl-surgery/

Interesting Article about arthritis after knee surgery.  We definitely recommend the AcuKnee System after surgery to reduce the possibilities of post surgical arthritis.

Dr. Brown
http://www.acuknee.com

Monday, March 10, 2014

KOOS Study


A word about our knee pain data. The KOOS test.

Patients and customers frequently ask us what the KOOS test is and how we collect our data. KOOS is an acronym for Knee Osteoarthritis Outcome Score. It is a reliable and highly validated measure of knee pain and function. We have been collecting data for almost three years. We typically test just prior to use and then at 1,4 and 8 week intervals.

The data displayed on our home page is very good but it is not a randomized, double blind, placebo controlled study. In fact, our data represents incredibly positive outcome seen with uncomplicated arthritis. We excluded patients with large cartilage defects, an acutely torn unrepairable meniscus, unstable knees due to ligament injuries or large leg alignment defects. Although these patients show similar but highly variable results.

Nonetheless the data is real and these patients are extremely pleased with their results. The patients who do well, stunningly well, have mild to moderate osteoarthritis. Furthermore, we have every indication that the disease progression is slowed or stopped. Most become pain-free and go to "maintain mode" and treat 2 times per week or less.

Our success rate is lower with severe knee pathology but a high percentage of patients
do spectacularly well--patients we did not expect to do well--and continue to surprise us every day with their success. One common characteristic these patients share is a disciplined approach to their own care and a willingness to precisely follow our treatment instructions.

Next week we will be sharing some patient outcomes that even we found very surprising. And soon thereafter we will post some select videos allowing patients to tell their stories directly.

Martin Brown, MD
www.acuknee.com